Infectious Agents and Cancer | Article collections

Submit a manuscript Register Contact us Follow
BioMed Central Support

Explore journal

Advertisement

Articles

HPV Prevention

Edited by: Dr Silvia de Sanjose

Collection published: 20 December 2012

Last updated: 29 December 2012

Human Papilloma Virus (HPV) is a major leading cause of Human Cancer. Through this series we would like to highlight the quality and the breadth of the research being carried out on the Control and Prevention of HPV and HPV related disease. This series aims to bring together a diverse range of HPV related specialities featuring research that has as ultimate goal insights into HPV related disease reduction. Articles can have a wide range of topics such as those of natural history studies, impact of screening interventions or impact of HPV vaccines will be most welcome.

Relevant research papers published in Infectious Agents and Cancer will be added to the series, with commentary to explain their significance, or put them in context for no specialist readers. The section will include:

News on HPV research, highlight of events or articles that deserve particular attention for their relevance or controversy.
A major research article on HPV with priority for community trials or demonstration projects of preventive strategies.
A collection of relevant articles that relate to HPV disease reduction.

		Research article Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease Beatriz Serrano, Laia Alemany, Sara Tous, Laia Bruni, Gary M Clifford, Thomas Weiss, Francesc Bosch, Silvia de Sanjosé Infectious Agents and Cancer 2012, 7:38 (29 December 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
		Editorial HPV Prevention series Silvia de Sanjosé Infectious Agents and Cancer 2012, 7:37 (20 December 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
		Review HPV - immune response to infection and vaccination Margaret Stanley Infectious Agents and Cancer 2010, 5:19 (20 October 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
		Review Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline Mark Schiffman, Gary Clifford, Franco M Buonaguro Infectious Agents and Cancer 2009, 4:8 (1 June 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Mark Schiffman and colleagues discuss the recent reassessment by the World Health Organization International Agency for Research on Cancer (IARC) of the carcinogenicity of different HPV types.
		Commentary The evolving definition of carcinogenic human papillomavirus Philip E Castle Infectious Agents and Cancer 2009, 4:7 (11 May 2009) Abstract \| Full text \| PDF \| PubMed \| 1 comment
		Research article Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women Ralph P Insinga, Erik J Dasbach, Elamin H Elbasha, Kai-Li Liaw, Eliav Barr Infectious Agents and Cancer 2007, 2:15 (12 July 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
		Research article Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy Maria Tornesello, Maria Duraturo, Luigi Buonaguro, Gabriele Vallefuoco, Roberto Piccoli, Stefano Palmieri, Franco M Buonaguro Infectious Agents and Cancer 2007, 2:1 (3 January 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central

		Research article Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease Beatriz Serrano, Laia Alemany, Sara Tous, Laia Bruni, Gary M Clifford, Thomas Weiss, Francesc Bosch, Silvia de Sanjosé Infectious Agents and Cancer 2012, 7:38 (29 December 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
		Editorial HPV Prevention series Silvia de Sanjosé Infectious Agents and Cancer 2012, 7:37 (20 December 2012) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
		Review HPV - immune response to infection and vaccination Margaret Stanley Infectious Agents and Cancer 2010, 5:19 (20 October 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
		Review Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline Mark Schiffman, Gary Clifford, Franco M Buonaguro Infectious Agents and Cancer 2009, 4:8 (1 June 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Mark Schiffman and colleagues discuss the recent reassessment by the World Health Organization International Agency for Research on Cancer (IARC) of the carcinogenicity of different HPV types.
		Commentary The evolving definition of carcinogenic human papillomavirus Philip E Castle Infectious Agents and Cancer 2009, 4:7 (11 May 2009) Abstract \| Full text \| PDF \| PubMed \| 1 comment
		Research article Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women Ralph P Insinga, Erik J Dasbach, Elamin H Elbasha, Kai-Li Liaw, Eliav Barr Infectious Agents and Cancer 2007, 2:15 (12 July 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
		Research article Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy Maria Tornesello, Maria Duraturo, Luigi Buonaguro, Gabriele Vallefuoco, Roberto Piccoli, Stefano Palmieri, Franco M Buonaguro Infectious Agents and Cancer 2007, 2:1 (3 January 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central